Free Access
Issue
Med Sci (Paris)
Volume 34, Number 5, Mai 2018
Page(s) 379 - 382
Section Le Magazine
DOI https://doi.org/10.1051/medsci/20183405003
Published online 13 June 2018
  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016 ; 66 : 7–30. [CrossRef] [PubMed] [Google Scholar]
  2. Burris HA, 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997 ; 15 : 2403–2413. [CrossRef] [PubMed] [Google Scholar]
  3. Conroy T, Desseigne F, Ychou M, et al. Folfirinox versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011 ; 364 : 1817–1825. [CrossRef] [PubMed] [Google Scholar]
  4. Costello E, Greenhalf W, Neoptolemos JP. New biomarkers and targets in pancreatic cancer and their application to treatment. Nat Rev Gastroenterol Hepatol 2012 ; 9 : 435–444. [CrossRef] [PubMed] [Google Scholar]
  5. Iovanna J, Mallmann MC, Goncalves A, et al. Current knowledge on pancreatic cancer. Front Oncol 2012 ; 2 : 6. [CrossRef] [PubMed] [Google Scholar]
  6. Vincent A, Herman J, Schulick R, et al. Pancreatic cancer. Lancet 2011 ; 378 : 607–620. [CrossRef] [PubMed] [Google Scholar]
  7. Carolane Seiller C, Dubois B. Rôle protumoral des lymphocytes B dans le cancer du pancréas : vers de nouvelles pistes thérapeutiques. Med Sci (Paris) 2017; 33 : 859–62. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  8. Nicolle R, Blum Y, Marisa L, et al. Pancreatic adenocarcinoma therapeutic targets revealed by tumor-stroma cross-talk analyses in patient-derived xenografts. Cell Rep 2017 ; 21 : 2458–2470. [CrossRef] [PubMed] [Google Scholar]
  9. Dormoy V, Massfelde T. La métabolomique au service de la médecine : l’exemple du carcinome rénal. Med Sci (Paris) 2013 ; 29 : 463–468. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.